Stay informed about the latest updates and insights from the Conscio Group, the group of companies dedicated to improving health worldwide through quality science.

8 April 2025

Batch Release Testing and QP Certification: The Backbone of Pharmaceutical Quality Assurance

Are strict pharmaceutical regulations slowing your EU market entry? You're not alone. Navigating the complex landscape of batch release testing can be challenging, particularly for pharmaceutical manufacturers outside the EU.

7 April 2025

Conscio Group Appoints Gary Chambers as Executive Vice President of Strategy and Marketing

April 3, 2025 – Conscio Group, a leading scientific service provider for the pharmaceutical industry, announces the appointment of Gary Chambers as Executive Vice President (EVP) of Strategy and Marketing.

25 November 2024

Expediting Biosimilar development: Streamlining the path from research to market

A free webinar on the future of biosimilar pathway to approval is now available for registration.

2 October 2024

Conscio Group and Kiel Labs Announce Strategic Partnership

Conscio Group, a European network of GMP/GLP/GCP/IEC-certified contract R&D service providers, and Kiel Laboratories, Inc., a leading U.S. pharmaceutical research and development company, today announced a strategic partnership to enhance drug development capabilities and market access for their respective clients.

4 September 2024

Meet us at the heart of Pharma at CPHI 2024

Conscio Group is attending CPHI 2024 in Milan, Italy.

10 June 2024

Vorteile sequentieller Designs in Bioäquivalenzstudien

Entdecken Sie die Leistungsfähigkeit sequentieller Designs für Bioäquivalenzstudien, einem entscheidenden Schritt in der Entwicklung von Generika: Ihre praktische Umsetzung, statistische Analyse und das Wohlbefinden der Freiwilligen.

14 May 2024

A new partnership with Reference Analytics GmbH

The Conscio Group is expanding its range of services in Austria by acquiring Reference Analytics GmbH.

4 December 2023

Our new clinical unit in Ostrava (CZ) comes to life

It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava (CZ) with 36-beds capacity has been opened.

18 July 2023

Challenges of a large-scale study of breast cancer

Our bioanalytical experts and a high-profile client team up for the development of a new breast cancer treatment.

4 July 2023

Microbiology and Batch Testing: Bridging Across Sectors

Discover LVA GmbH and EL Labs s.r.o., the only Conscio Group subsidiaries at the intersection of our Pharma and Nutrition end-to-end solutions.